Ntambwe Malangu

Sefako Makgatho Health Sciences University

Prof Ntambwe Malangu, born in Kabinda, Congo (DRC), is a pharmacoepidemiologist with public health expertise in drug safety issues. He is currently the Head of Department of Epidemiology and Biostatistics at the School of Public Health at Sefako Makgatho Health Sciences University, Pretoria, South Africa; and the Production Editor for PULA: Bostwana Journal for African studies as well as a reviewer for a handful of international peer-reviewed journals. He has worked in both private and public sector of the healthcare industry in several African countries. From 2006, he has been working as an international health consultant and technical advisor with major development partners. In this capacity, he has contributed to several health systems strengthening initiatives across the Anglophone, Lusophone and Francophone African countries. He is a well-known trainer in supply chain management of health commodities and pharmaceuticals as well as in pharmacy and public health practice themes. Malangu holds a Bachelor degree in Pharmacy from the University of Kinshasa (1991) and a Master of Medical Science degree (Pharmacology and Toxicology) from the Medical University of Southern Africa (2003), a PhD degree (Pharmacoepidemiology and Pharmacovigilance, 2007) and a Doctor of Medical Sciences (Injury Epidemiology and Toxicovigilance) from the University of Limpopo (2012). Malangu has over 60 publications including scientific abstracts and letters, books, book chapters and full papers.

Ntambwe Malangu

2books edited

5chapters authored

Latest work with IntechOpen by Ntambwe Malangu

This book is a fruit of a collaborative work from several international scientists. It will be a useful resource for researchers, students, and clinicians. Each individual chapter could serve as a prescribed reading for postgraduate students and clinicians specializing in and practicing clinical pharmacology and toxicology, pharmacotherapy and pharmacotherapeutics, pharmacovigilance, and toxicovigilance, as well as those involved in clinical research, drug discovery, and development. Every chapter in this book discusses and provides illustrations on the theme discussed based on authors' understanding and experience while summarizing existing knowledge. In doing so, each chapter provides a new insight that would benefit a novice as well as a seasoned reader in understanding the pharmacokinetic mechanisms and risk factors involved in the occurrence of adverse effects of drugs.

Go to the book